A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously ... of disease was ultimately complicated by acute disseminated encephalomyelitis and death.

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia ...

The Committee recommends that a study estimating utility values using directly observed health-related quality of life values (such as EQ 5D scores) in patients with myelodysplastic syndromes, chronic ...